Page results
-
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
This week, clinical leaders across north central London have written to our local newspapers, outlining the rationale for temporary changes to children and young people's services across the region. The letter reflects on some of the lessons learnt from the first wave of the COVID-19 pandemic and the need to plan ahead for a likely second surge and a busy winter with all of the challenges that will bring. You can read the letter in full here:
-
Anyone can develop oesophageal cancer, however there are factors that can increase the risk. Watch our series of videos and find out what oesophageal cancer is, the signs and symptoms and learn how it can be diagnosed and treated.
-
Prime Minister, Sir Keir Starmer, was joined by Health and Social Care Secretary, Wes Streeting, for a tour of the University College Hospital Grafton Way Building where they met staff and patients.
-
UCLH cancer services including radiotherapy has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information.
-
Johanna Moss was appointed to the Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
File results
-
FOI/2023/0156 - Digital sepsis alerts for obstetric patients
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0162 - ICT and Procurement strategy and organisational charts
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0192 - Non emergency patient transport - NEPTS and taxi procurement
-
FOI/2023/0195 - Patient level costing system and integrated data platform